Skip to content

Study Safety and Effectiveness of CURVE Laser Therapy for Circumference Reduction of the Waistline.

A RandomizEd DoUble Blinded ControllEd Study to Evaluate the Safety and Effectiveness of the CURVE Low Level Laser Therapy (LLLT) for Circumference Reduction of the Waistline.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02909790
Enrollment
40
Registered
2016-09-21
Start date
2016-05-31
Completion date
2016-09-30
Last updated
2016-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Injury to Subcutaneous Tissue

Brief summary

The purpose of this study is to assess the safety and effectiveness of the CURVE Low-Level Laser Therapy for circumference reduction of the waistline.

Detailed description

This study involves research to obtain information on the CURVE. In recent years Low Level Laser therapy devices have grown in popularity due to increased scientific understanding of their mechanism of action, published research, and patients demand for more non-invasive procedures in body contour and fat reduction. LLL are widely used in health clinics, medical spas and in aesthetic medicine in the treatment of cellulite and for inflammatory conditions such as carpal tunnel syndrome. This study will further evaluate the effectiveness of low-level laser treatments without the extraction of adipose tissue using liposuction or in combination with other treatment modalities.

Interventions

DEVICECurve Low Level Laser Therapy

Subjects assigned to the treatment group will be treated with 4 multi-paddle low-level diode laser consisting of 8 independent diode laser heads per treatment paddle, each emitting 630-680nm (red) laser light with each diode generating 40mW output (CURVE Laser - manufactured by YOLO Medical Inc.).

Sponsors

Yolo Medical Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

1. Subject is an adult ≥ 18 years old and \<65 years of age 2. Subject has maintained a stable weight for the past 6 months (variation no greater than 10 lbs. from usual weight). 3. Subject is willing to maintain current diet and exercise regimen for the duration of study. 4. Subject is willing and able to provide written informed consent. 5. Subject is willing to return for all scheduled and required visits. 6. Subject is willing to comply with post-laser treatment cardiovascular exercise. 7. Subject is willing to comply with food and fluid requirements pre-treatment and post-treatment.

Exclusion criteria

1. Subject is on an active weight control regimen. 2. Subject has a pacemaker. 3. Subject has a history of epilepsy. 4. Subject has a history of any type of cancer, including skin cancer. 5. Subject had a prior surgical intervention for body sculpting/weight loss such as liposuction, abdominoplasty, gastroplasty, lap band surgery, etc. 6. Subject has a medical, physical, or other contraindications for body sculpting/weight loss. 7. Subject has an active infection, wound or other external trauma to the areas to be treated with the laser. 8. Subject is pregnant, breast feeding, or planning pregnancy prior to study end. 9. Subject is participating in any treatment other than the study procedure (existing or new) to promote body contouring and/or weight loss during the course of study participation. 10. Subject is participating in another research study of a device, medication, biologic, or other agent within 30 days or could, in the opinion of the investigator, affect the results of this study.

Design outcomes

Primary

MeasureTime frame
Reduction of girth measurements for the waistline after successful completion of the three (3) week study procedure.3 weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026